FMR CORP 13D/13G Filings for Aprea Therapeutics, Inc. (APRE)

FMR CORP 13D and 13G filings for Aprea Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-10
09:23 am
Sale		 2021-02-09 13G Aprea Therapeutics, Inc.
APRE		 FMR CORP 1
0.000%		 -63,063decrease
(-100.00%)		 Filing
2021-02-08
10:15 am
Sale		 2021-02-05 13G Aprea Therapeutics, Inc.
APRE		 FMR CORP 63,064
5.953%		 -44,057decrease
(-41.13%)		 Filing